Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.29 - $0.59 $0 - $0
-1 Reduced 0.01%
10,000 $5,000
Q3 2022

Nov 14, 2022

SELL
$0.35 - $0.65 $35 - $66
-102 Reduced 1.01%
10,001 $3,000
Q2 2022

Aug 15, 2022

SELL
$0.44 - $1.77 $54,438 - $218,991
-123,724 Reduced 92.45%
10,103 $7,000
Q4 2021

Feb 14, 2022

BUY
$1.75 - $3.03 $156,177 - $270,409
89,244 Added 200.17%
133,827 $244,000
Q3 2021

Nov 15, 2021

BUY
$2.41 - $3.33 $50,366 - $69,593
20,899 Added 88.24%
44,583 $124,000
Q2 2021

Aug 11, 2021

BUY
$2.24 - $3.9 $22,590 - $39,331
10,085 Added 74.16%
23,684 $72,000
Q1 2021

May 17, 2021

BUY
$3.19 - $5.4 $9,940 - $16,826
3,116 Added 29.72%
13,599 $47,000
Q4 2020

Feb 16, 2021

BUY
$3.06 - $4.17 $32,077 - $43,714
10,483 New
10,483 $33,000
Q1 2020

May 15, 2020

SELL
$3.3 - $6.84 $42,134 - $87,333
-12,768 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$3.61 - $6.75 $8,487 - $15,869
-2,351 Reduced 15.55%
12,768 $74,000
Q3 2019

Nov 14, 2019

SELL
$4.62 - $7.11 $6,126 - $9,427
-1,326 Reduced 8.06%
15,119 $72,000
Q2 2019

Aug 14, 2019

BUY
$5.68 - $8.68 $24,651 - $37,671
4,340 Added 35.85%
16,445 $121,000
Q1 2019

May 15, 2019

BUY
$7.27 - $9.07 $4,158 - $5,188
572 Added 4.96%
12,105 $99,000
Q4 2018

Feb 14, 2019

BUY
$6.59 - $14.47 $76,002 - $166,882
11,533 New
11,533 $79,000

About Galmed Pharmaceuticals Ltd.


  • Ticker GLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,088,400
  • Market Cap $7.78M
  • Description
  • Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...
More about GLMD
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.